Full Press Release Details
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, July 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors. Outset Medical that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On July 7, 2023, Outset Medical made a public disclosure stating that it had received a Warning Letter from the United States Food and Drug Administration (FDA). The letter pointed out that certain materials on the company's website were promoting the use of continuous renal replacement therapy (CRRT), which is a treatment modality not currently indicated for the Tablo Hemodialysis System. Additionally, the FDA noted that the TabloCart with Prefiltration requires prior 510(k) clearance for marketing authorization.
As a consequence of this news, Outset Medical's stock price declined by $1.20, representing a 5.9% decrease, and the shares closed at $19.26 per share on July 10, 2023. This decline in stock value resulted in financial losses for investors.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising